Acute Visual Loss after Intravitreal Bevacizumab Injection in a Patient with Ocular Ischemic Syndrome
Journal of the Korean Ophthalmological Society
;
: 1893-1897, 2012.
Article
in Korean
| WPRIM
| ID: wpr-134198
ABSTRACT
PURPOSE:
To report a patient with ocular ischemic syndrome who suffered from sudden decrease in visual acuity after bevacizumab injection. CASESUMMARY:
A 70-year-old patient visited the Department of Ophthalmology due to progressively decreasing visual acuity in the right eye. Corrected visual acuity in his right eye was 0.1 on the first visit; ocular ischemic syndrome was suspected. Despite panretinal photocoagulation, severe iris neovascularization was still present in the right eye. Intravitreal bevacizumab injection was performed to regress the iris neovascularization. One day after injection, iris neovascularization regressed significantly, however, visual acuity was decreased to finger counting.CONCLUSIONS:
In ocular ischemic syndrome, bevacizumab injection for reduction of iris neovascularization should be carefully considered due to possibility of acute visual loss.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Ophthalmology
/
Visual Acuity
/
Iris
/
Eye
/
Antibodies, Monoclonal, Humanized
/
Fingers
/
Bevacizumab
/
Light Coagulation
Limits:
Aged
/
Humans
Language:
Korean
Journal:
Journal of the Korean Ophthalmological Society
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS